| scholarly article | Q13442814 |
| P50 | author | Travice De Silva | Q64623399 |
| Frank M Faraci | Q86046795 | ||
| P2093 | author name string | Mary L Modrick | |
| Dale A Kinzenbaw | |||
| Lindsey D Reinhardt | |||
| P2860 | cites work | Selective ROCK2 inhibition in focal cerebral ischemia | Q24614558 |
| ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells | Q24646579 | ||
| Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity | Q27642704 | ||
| Rho Kinases in Health and Disease: From Basic Science to Translational Research | Q28080702 | ||
| Specificity and mechanism of action of some commonly used protein kinase inhibitors | Q28344791 | ||
| Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase | Q29615195 | ||
| Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | Q30574731 | ||
| Activation of cerebellar climbing fibers increases cerebellar blood flow: role of glutamate receptors, nitric oxide, and cGMP. | Q32115994 | ||
| Penetrating arterioles are a bottleneck in the perfusion of neocortex | Q33267690 | ||
| Rho-associated kinase activity is a predictor of cardiovascular outcomes. | Q33911873 | ||
| Postischemic reperfusion causes smooth muscle calcium sensitization and vasoconstriction of parenchymal arterioles | Q34087786 | ||
| Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation | Q34315697 | ||
| Vascular TRP channels: performing under pressure and going with the flow | Q34428913 | ||
| Regional Blood Flow in the Normal and Ischemic Brain Is Controlled by Arteriolar Smooth Muscle Cell Contractility and Not by Capillary Pericytes | Q34482679 | ||
| Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism | Q34601386 | ||
| Genetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism | Q34892807 | ||
| Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation | Q34957350 | ||
| Protecting against vascular disease in brain | Q34979773 | ||
| Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease. | Q35128837 | ||
| ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury | Q36540884 | ||
| Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. | Q36787307 | ||
| Microvascular Dysfunction and Cognitive Impairment. | Q36839870 | ||
| Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration | Q36957712 | ||
| Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection | Q37079168 | ||
| Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice | Q37092280 | ||
| Effects of Early Post-Ischemic Reperfusion and tPA on Cerebrovascular Function and Nitrosative Stress in Female Rats | Q37623559 | ||
| Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging | Q38100421 | ||
| Regulation of large cerebral arteries and cerebral microvascular pressure | Q38137923 | ||
| Hypertension: renin-angiotensin-aldosterone system alterations | Q38376304 | ||
| Acidosis dilates brain parenchymal arterioles by conversion of calcium waves to sparks to activate BK channels. | Q42351857 | ||
| Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. | Q42799773 | ||
| Role of inwardly rectifying K(+) channels in K(+)-induced cerebral vasodilatation in vivo | Q43510277 | ||
| Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. | Q43590596 | ||
| Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries | Q43702962 | ||
| Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system | Q44590599 | ||
| Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes | Q45214949 | ||
| Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response | Q46054871 | ||
| Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial | Q46591653 | ||
| Cerebral vascular effects of angiotensin II: new insights from genetic models | Q46644984 | ||
| Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction | Q46745889 | ||
| Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors | Q48315597 | ||
| Rho kinase activity governs arteriolar myogenic depolarization. | Q49157136 | ||
| Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. | Q52681738 | ||
| Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. | Q53628625 | ||
| Effect of nitric oxide and potassium channel agonists and inhibitors on basilar artery diameter. | Q54167219 | ||
| Effect of norepinephrine on rat basilar artery in vivo | Q70555530 | ||
| Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension | Q73727736 | ||
| Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase | Q77195720 | ||
| Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes | Q79377957 | ||
| Blood pressure and stroke: an overview of published reviews | Q79843018 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 809-817 | |
| P577 | publication date | 2016-07-18 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function | |
| P478 | volume | 68 |
| Q90685517 | Anti-arrhythmic properties of non-antiarrhythmic medications |
| Q95359203 | Augmented astrocyte microdomain Ca2+ dynamics and parenchymal arteriole tone in angiotensin II-infused hypertensive mice |
| Q39116577 | Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke |
| Q51741060 | Changes in Cerebral Arteries and Parenchymal Arterioles With Aging: Role of Rho Kinase 2 and Impact of Genetic Background. |
| Q54979587 | Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging. |
| Q47710820 | Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7. |
| Q92298812 | KD025 (SLx-2119) suppresses adipogenesis at intermediate stage in human adipose-derived stem cells |
| Q39444002 | Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. |
| Q33693655 | Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin. |
| Q90267047 | Spreading depolarizations trigger caveolin-1-dependent endothelial transcytosis |
Search more.